Company intelligence / Profile preview

Korea Investment & Securities

Ownership: Private
Employees: ~2641
Development stage: Other

Overview

Korea Investment & Securities is a leading South Korean investment bank and securities firm providing financial services such as securities dealing, brokerage, underwriting, online trading, and asset management. It does not develop drugs or healthcare products itself but may invest in life science/biotech companies through its funds.

Industry: Investors

Partnerships

Carlyle Group (strategic partnership announced October 2024)

Beyond the preview

Go deeper on Korea Investment & Securities.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Korea Investment & Securities.

Explore the full profile